Impact on Opioid Use of Bundling Medication-assisted Treatment With mHealth

Summary

The primary aim of this study is to measure and explain the impact on long-term opioid use when medication-assisted treatment (MAT) is bundled with an evidence-based mobile-health system (A-CHESS).

Conditions

• Opioid Use Disorder

Interventions

BEHAVIORAL

MAT + A-CHESS

Subjects randomized to MAT + A-CHESS will receive MAT plus the A-CHESS recovery support system which provides: 1. Self-directed, interactive modules that teach basic recovery support, harm-reduction, and psychosocial functioning skills. 2. The latest information about addiction and recovery support, monitoring prompts, and peer and family support. 3. Advice on where to go for help and on how to make the best use of health and human services; and 4. A way to talk with experts in the area of addiction and other study participants by sending anonymous messages in the A-CHESS discussion groups. 5. A way to keep your health care team up to date through reports based on information entered into A-CHESS (i.e. alcohol and drug use, depression, MAT side effects).

OTHER

MAT

Patients will receive treatment consisting of a recovery plan, appropriate pharmacology, routine urine screens, and regularly scheduled behavioral interventions, such as monthly group counseling sessions or sessions with a recovery coach. "Appropriate pharmacology" may include methadone; naltrexone; buprenorphine; and in the case of overdose, naloxone; and other medications and combinations of medications as part of the patient's standard clinical care.

Sponsors & Collaborators

• Stanley Street Treatment and Resources (SSTAR)

  collaborator UNKNOWN

• Gosnold on Cape Cod

  collaborator UNKNOWN

• ARC Community Services, Inc.

  collaborator UNKNOWN

• National Institute on Drug Abuse (NIDA)

  collaborator NIH

• University of Wisconsin, Madison

  lead OTHER

Principal Investigators

• David H Gustafson, PhD · UW Madison

Study Design

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

DOUBLE

Model

PARALLEL

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2016-04-21

Primary Completion

2020-04-08

Completion

2020-04-08

Countries

• United States

Study Locations